Mablink’s R&D team authored a scientific article published today (March 9) in the journal « Pharmaceuticals ». The paper « Exatecan Antibody Drug Conjugates based on a hydrophilic polysarcosine Drug-Linker platform » characterizes a …
A new peer-reviewed scientific publication introducing our ADC drug-linker platform is now available online. Abstract Antibody-drug conjugates (ADCs) convey highly potent anticancer drugs to antigen-expressing tumor cells, thereby sparing healthy …
Our new publication is now available online. Abstract: We report the on-resin synthesis of monodisperse (i.e. discrete) polysarcosine compounds and their uses as an hydrophobicity masking entity for the construction of …
